# STOCKHOLM 1.0
#=GF ID   Synuclein
#=GF AC   PF01387.21
#=GF DE   Synuclein
#=GF AU   Bateman A;0000-0002-6982-4660
#=GF SE   [1]
#=GF GA   23.30 23.30;
#=GF TC   23.60 23.30;
#=GF NC   23.00 22.90;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch -E 1000 --cpu 4 -Z 75585367 HMM pfamseq
#=GF TP   Family
#=GF WK   Synuclein
#=GF RN   [1]
#=GF RM   9750188
#=GF RT   The synuclein family. 
#=GF RA   Lavedan C; 
#=GF RL   Genome Res 1998;8:871-880.
#=GF RN   [2]
#=GF RM   11806835
#=GF RT   The synucleins. 
#=GF RA   George JM; 
#=GF RL   Genome Biol 2002;3:REVIEWS3002.
#=GF DR   INTERPRO; IPR001058;
#=GF DR   SO; 0100021; polypeptide_conserved_region;
#=GF CC   There are three types of synucleins in humans, these are called
#=GF CC   alpha, beta and gamma.  Alpha synuclein has been found mutated
#=GF CC   in families with autosomal dominant Parkinson's disease. A
#=GF CC   peptide of alpha synuclein has also been found in amyloid
#=GF CC   plaques in Alzheimer's patients. 
#=GF SQ   12
#=GS H2THY3_TAKRU/1-124      AC H2THY3.1
#=GS G3PW48_GASAC/1-122      AC G3PW48.1
#=GS I3KCI5_ORENI/1-124      AC I3KCI5.1
#=GS A0A3B5PWT6_XIPMA/1-124  AC A0A3B5PWT6.1
#=GS A0A5F8HL03_MONDO/1-122  AC A0A5F8HL03.1
#=GS M3W8Q2_FELCA/1-125      AC M3W8Q2.3
#=GS SYUG_HUMAN/1-124        AC O76070.2
#=GS H9GLG0_ANOCA/1-124      AC H9GLG0.2
#=GS W5N3W3_LEPOC/1-121      AC W5N3W3.1
#=GS G1RPQ5_NOMLE/1-125      AC G1RPQ5.2
#=GS F6T1V6_MONDO/1-128      AC F6T1V6.1
#=GS A0A2K5CEE9_AOTNA/1-131  AC A0A2K5CEE9.1
H2THY3_TAKRU/1-124                 MDAFMKGFSKAKDGVVAAAEKTKQGVTGAAEMTKDGVMFVGTKTKDG....VTVVAGKTVSGVSQVGGAMVTGVTAVAQKTVESAGSIAAATG..LVKKE.......PGKQGDDAAT.AENMAESPDVTDPAEATEED
G3PW48_GASAC/1-122                 MDAFKKGFSKARDGVAAVAEKTKQGVTGAAEMTKDGVMFVGNKTKDG....VTTDFPTAVSGVSQVGGAMVTGVTAVAHKTVEGAGNMVVATG..LVKKD.......PAKQSDEASA.VQDMAESPVDTDPADAME..
I3KCI5_ORENI/1-124                 MDALMKGFSKAKDGVVAAAEKTKQGVTGAAEMTKDGVMYVGTKTKDG....VTTVAGKTVSGVSQVGEAVVTGVTAVAQKTVEGAGTIAAATG..LVKKD.......PAKQSDDASA.VQDVAESPVDTDPADVTEED
A0A3B5PWT6_XIPMA/1-124             MDALMKGFSKAKDGVVAAAEKTKQGVTGAAEMTKDGVMYVGTKTKDG....VSTVAEKTVSGVSHVGGAVVTGVTAVAQKTVEGAGNIAAATG..LVKKD.......PAKQGEDVSA.VPDAVESPIDTDSTEPTEED
A0A5F8HL03_MONDO/1-122             MDVFKKGFSIAKEGVVGAVEKTKQGVTEAAEKTKEGVMYVGTKTKEGVVQSVTSVAEKTKEQANLVSDVMVASVNTVANKTVEEAENIVVTSG..IVRKEDLVNPA.QPEHGAP.............EEQPAEAAEVT
M3W8Q2_FELCA/1-125                 MDVFKKGFSIAKEGVVGAVEKTKQGVTEAAEKTKEGVMYVGAKTKENVVQSVTSVAEKTKEQANAVSEAVVTSVNTVAIKTVEEAENIAITSG..VIRKEDLEQPA.PSQEDKA..........AKAEEEVAEEAKSG
SYUG_HUMAN/1-124                   MDVFKKGFSIAKEGVVGAVEKTKQGVTEAAEKTKEGVMYVGAKTKENVVQSVTSVAEKTKEQANAVSEAVVSSVNTVATKTVEEAENIAVTSG..VVRKEDLRPSA.PQQEGEA..........SKEKEEVAEEAQS.
H9GLG0_ANOCA/1-124                 MDVFKKGFSIAKEGVVAAAEKTKQGVTEAAEKTKEGVMYVGAKTKEGVVQSVTSVAEKTKEQANLVGESVVASVNTVAKQTVEGAETVVSSTG..VVKMEDLHPEQ.PEEPLAD...........AEEDAPVEATETS
W5N3W3_LEPOC/1-121                 MDVLKKGFSIAKEGVVAAAEKTKQGVEEAAAKTKEGVMYVGTKTKEGVVHSVNTVAQKTTEQANIVGETVVGSANQVSAKTVEGVENVVASTG..VVNPDDAV....NQEDFSR...........PPEGTVEQATDAV
G1RPQ5_NOMLE/1-125                 MDVFMKGLSMAKEGVVAAAEKTKQGVTEAAEKTKEGVLYVGSKTREGVVQGVASVAEKTKEQASHLGGAVFS...........GAGNIAAATG..LVKREEFPTDLKPEEVAQEAAEEPLIEPLMEPEGESYEDPPQE
F6T1V6_MONDO/1-128                 MDMFMKGLSMAKEGVVAAAEKTKQGVTEAAEKTKEGVLYVGSEIRSK.........DRARGSGSVVRDQSNESTEGITMGGIRGDDGSSVGVGRVLVKSSQWWHGI.PEEVGQEVGEEPMAEPLLDTEGESYEEPPQE
A0A2K5CEE9_AOTNA/1-131             MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVTTVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGNIAAATG..FVKKDHLG....KSEEGAPQEGILEDMPV.DPDNEAYEMPSEE
#=GC seq_cons                      MDsFhKGFShAKEGVVAAAEKTKQGVTEAAEKTKEGVMYVGoKTK-G....VToVA-KTpppsstVGtAVVouVssVApKTVEGAtNIusuTG..lVKK-ph.....Ptcpupc...........ss-s-ssEsscpp
